NCT00004652View on ClinicalTrials.gov

Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 1993

Conditions
Tourette Syndrome
Interventions
DRUG

pimozide

All Listed Sponsors
collaborator

University of Rochester

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004652 - Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome | Biotech Hunter | Biotech Hunter